US5387589A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method of treating ocular inflammation
Assignee: University of Louisville Research Foundation ULRF
•
Filing: 1992-11-17
•
Granted: 1995-02-07
•
Expires: 2012-11-17
Abstract
Abstract Disclosed is a method of treating ocular inflammation in a mammal in need of such treatment, including administering to the mammal an anti-inflammatory amount of rapamycin.
Inventors
- 👤 Prasad S. Kulkarni
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-07 13:28
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/70; A61K31/33; A61K31/335; A61K31/365; A61K31/395; A61K31/435; A61K31/44; A61K31/445; A61P; A61P27/00; A61P27/02; A61P29/00
Claims Analysis
Total Claims: 10
Claim 1
Independent Claim
25 words
A method for treating ocular inflammation in a mammal in need of said treatment, comprising administering to said mammal an effective anti-inflammatory amount of rapamycin.
Claim 2
Independent Claim
25 words
A method for treating ocular inflammation in a mammal in need of said treatment, comprising administering to said mammal an effective anti-inflammatory amount of rapamycin.
Claim 3
Dependent Claim
39 words
The method according to claim 1 in which said ocular inflammation is selected from the group consisting of uveitis, conjunctivitis, episcleritis, scleritis, optic neuritis, retrobulbar neuritis, ocular inflammation following ocular surgery, and ocular inflammation resulting from physical eye trauma.
Claim 4
Dependent Claim
28 words
The method of claim 1, wherein said rapamycin is administered by a route of administration selected from the group consisting of oral, parenteral, topical, transdermal and rectal administration.
Claim 5
Independent Claim
33 words
A method of providing symptomatic relief of, preventing the progression of, or eradicating ocular inflammation in a mammal in need of thereof, comprising administering to said mammal an effective anti-inflammatory amount of rapamycin.
Claim 6
Independent Claim
33 words
A method of providing symptomatic relief of, preventing the progression of, or eradicating ocular inflammation in a mammal in need of thereof, comprising administering to said mammal an effective anti-inflammatory amount of rapamycin.
Claim 7
Independent Claim
27 words
A method for treating ocular inflammation in a mammal in need of said treatment, comprising administering to said mammal between about 0.01 and 50 mg/kg/day of rapamycin.
Claim 8
Independent Claim
27 words
A method for treating ocular inflammation in a mammal in need of said treatment, comprising administering to said mammal between about 0.01 and 50 mg/kg/day of rapamycin.
Claim 9
Dependent Claim
20 words
The method of claim 5 wherein said rapamycin is administered in an amount of between about 0.1 to 35 mg/kg/day.
Claim 10
Dependent Claim
20 words
The method of claim 5 wherein said rapamycin is administered in an amount of between about 0.3 to 25 mg/kg/day.
References Cited (Backward Citations)
US3929992A
Cited
US3993749A
Cited
US4885171A
Cited
US5066493A
Cited
US4316885A
Cited
US4650803A
Cited
EP0406791A2
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1998-02-06 | 1998-08-08 | 1999-02-07 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2002-02-06 | 2002-08-08 | 2003-02-07 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2006-02-06 | 2006-08-08 | 2007-02-07 | $7700.00 | Window Closed / Lapsed |